Is it too soon to use blood-based biomarkers for AD in primary care? | S1E6

Springer Health+ IME: Podcast to Practice
05/08/2024 3 min Temporada 1 Episodio 6
Is it too soon to use blood-based biomarkers for AD in primary care? | S1E6

Listen "Is it too soon to use blood-based biomarkers for AD in primary care? | S1E6"

Descargar episodio Ver en sitio original

Episode Synopsis

Michelle Mielke discusses the current status for blood-based biomarker use in primary care in light of research presented at AAIC24.

More episodes of the podcast Springer Health+ IME: Podcast to Practice

Key Ketone Monitoring Updates and Highlights From the ADA 2025 Conference | S8E1 03/07/2025
Embracing gMG advances together: ensuring multidisciplinary collaboration 30/06/2025
Advances in gMG: implications for practice 24/06/2025
New and emerging therapies in gMG: going upstream, T-cell and B-cell targeted therapies 16/06/2025
New and emerging therapies in gMG: FcRn receptor antagonists and complement inhibition 16/06/2025
Deep dive into targeted therapies: understanding IDH1-mutant AML treatments | S6E3 16/06/2025
Understanding gMG 10/06/2025
Voices of gMG: enhancing patient-centric care 03/06/2025
Advancing AML treatment: evidence-based regimens and guidelines for R/R AML management | S6E2 03/06/2025
Unveiling the mysteries of molecular testing in AML: a guide for oncologists | S6E1 20/05/2025
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA